Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Fortress Biotech Inc (NQ: FBIO )

4.800 USD +0.200 (+4.35%)
Streaming Delayed Price Updated: 4:14 AM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Fortress Biotech Inc

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags News TPTX MRNA
From Benzinga
Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma
From GlobeNewswire News Releases
Stocks That Hit 52-Week Highs On Wednesday
On Wednesday morning, 90 companies achieved new highs for the year. Significant Points: United Parcel Service (NYSE: ... 
Tags MYOK 52/Week Highs PIC
From Benzinga
Thinking about buying stock in Myomo Inc, Parsley Energy, Fortress Biotech, AVEO Pharmaceuticals, or Nio Inc?
InvestorsObserver issues critical PriceWatch Alerts for MYO, PE, FBIO, AVEO, and NIO. 
From PR Newswire
Fortress Biotech's Series A Preferred Stock Shares Cross 12.5% Yield Mark
In trading on Monday, shares of Fortress Biotech Inc's 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) were yielding above the 12.5% mark based on its monthly dividend... 
Tags Stocks
From Market News Video
Thinking about buying stock in Delta Air Lines, Scientific Games, GameStop, Vertex Pharmaceuticals, or Fortress Biotech?
InvestorsObserver issues critical PriceWatch Alerts for DAL, SGMS, GME, VRTX, and FBIO. 
From PR Newswire
Fortress Biotech Announces Initiation of Phase 3 Studies of CAEL-101 in AL Amyloidosis
From GlobeNewswire News Releases
Alexion and Caelum Biosciences Announce Start of Phase 3 Studies of CAEL-101 in AL Amyloidosis
Alexion and Caelum Biosciences Announce Start of Phase 3 Studies of CAEL-101 in AL Amyloidosis 
From Business Wire News Releases
The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference
Biotech stocks continued to remain under pressure in the week ended Sept. 11, swayed by the volatility that was evident in the broader ... 
Tags HRMY BHC MacroGenics
From Benzinga
What Are The Best Penny Stocks To Buy Now? 4 Names To Know
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Stocks That Hit 52-Week Highs On Friday
During Friday's morning session, 23 stocks hit new 52-week highs. Interesting Highlights: The largest company by ... 
Tags Movers ISSC WIT
From Benzinga
The Daily Biotech Pulse: Positive Readout From Galapagos, Intersect ENT Strikes Distribution Deal, Sol Gel's Regulatory Filing Accepted For Review
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 10) Agenus Inc (NASDAQ: AGEN) Akouos Inc (NASDAQ: ... 
Tags INSP FDA RDHL
From Benzinga
4 Penny Stocks To Watch In September 2020; 1 Up Over 50% In Q3
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Fortress Biotech to Participate in Three September 2020 Virtual Investor Conferences
From GlobeNewswire News Releases
Mustang Bio to Participate in Three September 2020 Virtual Investor Conferences
From GlobeNewswire News Releases
Avenue Therapeutics Announces Publication of a Review of IV Tramadol
From GlobeNewswire News Releases
The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB) Akouos Inc (NASDAQ: ... 
Tags WST ITRM BLFS
From Benzinga
3 Penny Stocks Making New September Highs; 2 Up 60+% This Year
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Mustang Bio Announces Orphan Drug Designation for MB-107 for the Treatment of X-linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
From GlobeNewswire News Releases
Insider Buys Fortress Biotech's Stock
President & Chairman Rosenwald Lindsay A Md filed a Form 4 with the SEC on Tuesday, September 1. The insider bought 52,500 shares of ... 
Tags Market News Intraday Update Markets
From Benzinga
The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) 10X Genomics Inc (NASDAQ: TXG) Acutus Medical Inc (NASDAQ: ... 
Tags ACST AZN REPL
From Benzinga
Mustang Bio Announces Rare Pediatric Disease Designation for MB-207 for the Treatment of X-linked Severe Combined Immunodeficiency in Previously Transplanted Patients
From GlobeNewswire News Releases
54 Biggest Movers From Friday
Gainers VivoPower International PLC (NASDAQ: VVPR) shares jumped 69.1% to close at $8.25 on Friday after climbing 14% on Thursday. ... 
Tags PDEX GEVO FBRX
From Benzinga
Are These Penny Stocks To Invest In Or Trade? 3 Biotech Names To Know
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Why Fortress Biotech's Stock Is Trading Higher Today
Fortress Biotech (NASDAQ: FBIO) shares are trading higher on Friday after the company announced positive topline clinical efficacy ... 
Tags News FBIO Penny Stocks
From Benzinga
Fortress Biotech Announces Positive Topline Clinical Efficacy Results for CUTX-101, Copper Histidinate, for the Treatment of Menkes Disease
From GlobeNewswire News Releases
Fortress Biotech Announces $60 Million Loan Agreement with Oaktree Capital Management
From GlobeNewswire News Releases
36 Stocks Moving in Thursday's Pre-Market Session
Gainers PEDEVCO Corp. (NYSE: PED) shares rose 88.5% to $1.48 in pre-market trading after the company delivered an open letter to ... 
Tags UAVS COCP KXIN
From Benzinga
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
From GlobeNewswire News Releases
The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Abbott Laboratories (NYSE: ABT) Cancer Genetics Inc (NASDAQ: ... 
Tags CERS Offerings OVID
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.